NASDAQ:VKTX

Viking Therapeutics Stock Predictions

etoro logo Buy VKTX
*Your capital is at risk
$29.33
+0.0400 (+0.137%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

VKTX Prediction Chart

VKTX Predictions History

Latest community submissions for VKTX.
Predictor Target Session Target Price Result Direction Accuracy Score
Nov 20, 2025 $37.04 +2.78% $34.27 X 91.92% 0
Nov 20, 2025 $36.67 +1.73% $34.27 X 93.01% 0
Nov 20, 2025 Bullish $34.27 X 0
Nov 12, 2025 $45.00 +10.84% $40.78 V 89.65% 1
Oct 16, 2025 Bullish $34.73 X 0
Oct 16, 2025 $34.34 -2.22% $34.73 V 98.88% 2
Oct 16, 2025 $34.63 -1.39% $34.73 V 99.72% 5
Oct 16, 2025 $37.00 +5.35% $34.73 X 93.46% 0
Oct 13, 2025 $32.78 -2.32% $33.91 X 96.67% 0
Oct 13, 2025 $33.07 -1.45% $33.91 X 97.53% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for VKTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT VIKING THERAPEUTICS
Viking Therapeutics
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also dev...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE